Citation Impact
Citing Papers
Normal gut microbiota modulates brain development and behavior
2011 Standout
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
Catalytic enantioselective Reformatsky reaction with ketones
2008 StandoutNobel
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
2011 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Hypervalent iodine reagents as a new entrance to organocatalysts
2009 Standout
Catalytic Enantioselective Reformatsky Reaction with Aldehydes
2008 StandoutNobel
Oxymorphone: a review
2005
CH Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals
2012 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat
2008
The interplay between the intestinal microbiota and the brain
2012 Standout
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
2020
Nonpeptide Corticotropin-Releasing Hormone Receptor Type 1 Antagonists and Their Applications in Psychosomatic Disorders
2004
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
PRECLINICAL STUDY: Corticotropin‐releasing factor‐1 receptor antagonists decrease heroin self‐administration in long‐ but not short‐access rats
2009
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists
2002
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
2014
Complex α‐Pyrones Synthesized by a Gold‐Catalyzed Coupling Reaction
2007
Stress and disorders of the stress system
2009 Standout
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Biaryl Phosphane Ligands in Palladium‐Catalyzed Amination
2008 Standout
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
The molecular neurobiology of depression
2008 StandoutNature
Neurocircuitry of Addiction
2009 Standout
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
2002
Recent advances in Sonogashira reactions
2011 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
Die katalytische, asymmetrische Mukaiyama‐Michael‐Reaktion von Silylketenacetalen mit α,β‐ungesättigten Methylestern
2017 StandoutNobel
Total Synthesis of (+)-Yatakemycin
2006
Palladium‐Catalysed Cross‐Coupling and Related Processes: Some Interesting Observations That Have Been Exploited in Synthetic Chemistry
2009
The Reformatsky reaction in organic synthesis. Recent advances
2004
The Catalytic Asymmetric Mukaiyama–Michael Reaction of Silyl Ketene Acetals with α,β‐Unsaturated Methyl Esters
2017 StandoutNobel
Transition metals in organic synthesis: Highlights for the year 2005
2007
Metal‐Catalyzed Asymmetric Michael Addition in Natural Product Synthesis
2016
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Synthesis and Pharmacology of Galantamine
2005
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
IDPi‐Katalyse
2019 StandoutNobel
Pharmacological Actions of Multi-Target-Directed Evodiamine
2013
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Phenyl–Acetylene Bond Assembly: A Powerful Tool for the Construction of Nanoscale Architectures
2011 StandoutNobel
Catalytic Enantioselective Reformatsky Reaction with ortho-Substituted Diarylketones
2008 StandoutNobel
Alternative Synthetic Methods through New Developments in Catalysis by Gold
2008 Standout
Katalytische enantioselektive Reformatsky‐Reaktionen mit Aldehyden
2008 StandoutNobel
On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
2013
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
IDPi Catalysis
2019 StandoutNobel
Highly Diastereoselective and General Synthesis of Primary β-Fluoroamines
2011
Transition Metal Catalyzed Cycloisomerizations of 1,n-Allenynes and -Allenenes
2011 Standout
Biomedical Importance of Indoles
2013 Standout
Rapid, General Access to Chiral β-Fluoroamines and β,β-Difluoroamines via Organocatalysis
2009
Gold-Catalyzed Organic Transformations
2008 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Chemoenzymatic enantiodivergent total syntheses of (+)- and (−)-codeine
2009
Works of Ling‐Wei Hsin being referenced
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
2005
Selective reversible and irreversible ligands for the .kappa. opioid receptor
1992
The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1
2001
N-Cubylmethyl substituted morphinoids as novel narcotic antagonists
1996
Anthracenedione–methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles
2012
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
2000
High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
2019
Synthesis of Galanthamine Analogs as Acetylcholinesterase Inhibitors via Intramolecular Heck Cyclization
2003
Design and Synthesis of 2- and 3-Substituted-3-phenylpropyl Analogs of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: Role of Amino, Fluoro, Hydroxyl, Methoxyl, Methyl, Methylene, and Oxo Substituents on Affinity for the Dopamine and Serotonin Transporters
2008
Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: a potent radioligand for corticotropin-releasing hormone type 1 receptor
2000
Stereoselective synthesis of morphine fragments trans- and cis-octahydro-1H-benzo[4,5]furo[3,2-e]isoquinolines
2004
Development of Long-Acting Dopamine Transporter Ligands as Potential Cocaine-Abuse Therapeutic Agents: Chiral Hydroxyl-Containing Derivatives of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine
2002
Intramolecular Heck cyclization to the galanthamine-type alkaloids: total synthesis of (±)-lycoramine
2004
Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease
2013